Snowball logo
logo
6MK_logo

Merck & Co. Inc

70.60-1.60  (2.22%)
Start your journey to financial independence
Snowball will help you to track your portfolio, plan deposits to your brokerage account and support your passive income strategy with tools and community of investors
Start

Frequently asked questions

What sector does Merck & Co. Inc (6MK) operate in?

Merck & Co. Inc belongs to the Healthcare sector and operates in the Drug Manufacturers - General industry.

What is Merck & Co. Inc (6MK) current stock price?

As of the latest data, Merck & Co. Inc stock price is €70.60, with a previous close of €72.20. Merck & Co. Inc lost -€1.60 in the last trading session, representing a -2.22% loss.

What is Merck & Co. Inc (6MK) current market capitalization?

Merck & Co. Inc market cap is approximately 177.28 billion.

What is Merck & Co. Inc (6MK) Earnings Per Share (EPS)?

The trailing EPS is €5.99.

What is Merck & Co. Inc (6MK) Price-to-Earnings (P/E) ratio?

Merck & Co. Inc current P/E ratio is 11.79.

What is Merck & Co. Inc (6MK) EBITDA?

Merck & Co. Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 6.76 billion.

Does Merck & Co. Inc (6MK) pay dividends?

Yes. Merck & Co. Inc pays quarterly dividends with an annualized yield of 3.36% and an estimated annual payout of €2.77 per share.

When is the next ex-dividend date for Merck & Co. Inc (6MK)?

The next ex-dividend date is scheduled for September 16, 2025.

When is Merck & Co. Inc (6MK) next earnings report?

Merck & Co. Inc is expected to release its next earnings report on June 30, 2025.

What is Merck & Co. Inc (6MK) beta (volatility) score?

Merck & Co. Inc has a beta of 0.441, indicating lower volatility than the overall market.